Literature DB >> 18621861

Cardiovascular effects of prorenin blockade in genetically spontaneously hypertensive rats on normal and high-salt diet.

Dinko Susic1, Xiaoyan Zhou, Edward D Frohlich, Howard Lippton, Martha Knight.   

Abstract

Recent reports have demonstrated a potential role of tissue prorenin in the pathogenesis of cardiovascular and renal damage. This study was designed to examine the role of prorenin in the pathogenesis of target organ damage in spontaneously hypertensive rats (SHRs), the best naturally occurring experimental model of essential hypertension. To this end, we studied 20-wk-old male SHRs receiving a normal diet and 8-wk-old male SHRs given food with 8% NaCl. One-half the rats in each group were given prorenin inhibitor (PRAM-1, 0.1 mg.kg(-1).day(-1)) via osmotic minipumps; the other half served as controls. Arterial pressure, left ventricular function, cardiovascular mass indexes, cardiac fibrosis, and renal function were examined at the end of the experiment. Arterial pressure was unaffected by PRAM-1 in rats on either regular or salt-excess diets. In those rats receiving a normal diet, the blockade of prorenin activation consistently reduced left ventricular mass but affected no other variable. Salt-loaded rats given PRAM-1 for 8 wk demonstrated (1) reduced serum creatinine level, (2) decreased left ventricular mass, (3) improved left ventricular function, and (4) reduced left ventricular fibrosis. These data demonstrated that the blockade of nonproteolytic activation of prorenin exerted significant cardiovascular and renal benefit in SHRs with cardiovascular damage produced by salt excess and suggested that the activation of cardiovascular or renal prorenin may be a major mechanism that mediates cardiac and renal damage in this form of accelerated hypertension.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18621861     DOI: 10.1152/ajpheart.00055.2008

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  15 in total

1.  Increased dietary NaCl potentiates the effects of elevated prorenin levels on blood pressure and organ disease.

Authors:  Duncan J Campbell; Habib Karam; Patrick Bruneval; John J Mullins; Joël Ménard
Journal:  J Hypertens       Date:  2010-07       Impact factor: 4.844

Review 2.  Novel therapeutic targets for hypertension.

Authors:  Ludovit Paulis; Thomas Unger
Journal:  Nat Rev Cardiol       Date:  2010-06-22       Impact factor: 32.419

Review 3.  High salt intake as a multifaceted cardiovascular disease: new support from cellular and molecular evidence.

Authors:  Marcelo Perim Baldo; Sérgio Lamêgo Rodrigues; José Geraldo Mill
Journal:  Heart Fail Rev       Date:  2015-07       Impact factor: 4.214

4.  Salt-induced renal injury in spontaneously hypertensive rats: effects of nebivolol.

Authors:  Jasmina Varagic; Sarfaraz Ahmad; K Bridget Brosnihan; Javad Habibi; Roger D Tilmon; James R Sowers; Carlos M Ferrario
Journal:  Am J Nephrol       Date:  2010-11-02       Impact factor: 3.754

5.  ANG II-independent prorenin/(pro)renin receptor signaling pathways in the central nervous system.

Authors:  Yumei Feng
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-07-24       Impact factor: 4.733

Review 6.  Renin and prorenin receptor in hypertension: what's new?

Authors:  Genevieve Nguyen
Journal:  Curr Hypertens Rep       Date:  2011-02       Impact factor: 5.369

7.  Inhibiting (pro)renin receptor-mediated p38 MAPK signaling decreases hypoxia/reoxygenation-induced apoptosis in H9c2 cells.

Authors:  Yan Liu; Shenglin Zhang; Dechun Su; Jinqiu Liu; Yunpeng Cheng; Lu Zou; Wenqiang Li; Yinong Jiang
Journal:  Mol Cell Biochem       Date:  2015-02-25       Impact factor: 3.396

Review 8.  The (pro)renin receptor in health and disease.

Authors:  Atsuhiro Ichihara; Midori Sasaki Yatabe
Journal:  Nat Rev Nephrol       Date:  2019-11       Impact factor: 28.314

9.  Longitudinal Changes in Prorenin and Renin in the Chronic Renal Insufficiency Cohort.

Authors:  Monique E Cho; Carol Sweeney; Nora Fino; Tom Greene; Nirupama Ramkumar; Yufeng Huang; Ana C Ricardo; Tariq Shafi; Rajat Deo; Amanda Anderson; Katherine T Mills; Alfred K Cheung
Journal:  Am J Nephrol       Date:  2021-03-18       Impact factor: 3.754

10.  Lack of cardiac fibrosis in a new model of high prorenin hyperaldosteronism.

Authors:  Jörg Peters; Torsten Schlüter; Thomas Riegel; Barbara S Peters; Andreas Beineke; Ulrike Maschke; Norbert Hosten; John J Mullins; Rainer Rettig
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-09-11       Impact factor: 4.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.